New research on cannabis plant sex determination genetics reveals why cultivation practices directly impact therapeutic compound quality. Understanding these biological mechanisms helps explain the importance of controlled growing environments in medical cannabis production. This knowledge reinforces the clinical significance of standardized cultivation for consistent therapeutic outcomes.
Beer and cannabis could share ‘sex switch,’ study finds – Phys.org
Recent genomic research showing cannabis and hops genetic relationship through shared sex determination mechanisms has important clinical implications for understanding cannabinoid biosynthesis. This genetic similarity helps explain therapeutic compound development in both plants. Understanding these evolutionary relationships informs medical cannabis cultivar selection and personalized treatment approaches.
HIV/AIDS and Medical Marijuana: What Patients in the US Need to Know – Med Card District
Cannabis therapy for HIV patients shows promise for appetite stimulation and neuropathic pain management, but requires careful consideration of drug interactions with antiretroviral therapy. Clinical evidence supports modest but meaningful improvements in HIV-associated symptoms when properly integrated with comprehensive care. Patients should work closely with HIV specialists familiar with cannabis medicine to ensure safe and effective treatment protocols.
CBD in Vaporised Cannabis Boosts THC Levels in the Blood, Study Finds
The ‘THC+CBD’ condition produced significantly greater THC, OH-THC, and COOH-THC plasma levels than the ‘THC-alone’ condition, in terms of natural-log-transformed area-under-the-curve (AUC) and peak concentration (Cmax) values, with the exception of Cmax for OH-THC.
CBD in Vaporised Cannabis Raises THC Blood Levels, Study Finds—but Age Differences Remain Unclear
The ‘THC+CBD’ condition produced significantly greater THC, OH-THC, and COOH-THC plasma levels than the ‘THC-alone’ condition, in terms of natural-log-transformed area-under-the-curve (AUC) and peak concentration (Cmax) values, with the exception of Cmax for OH-THC.
CBD in Vaporised Cannabis Raises THC Blood Levels, Study Finds
The ‘THC+CBD’ condition produced significantly greater THC, OH-THC, and COOH-THC plasma levels than the ‘THC-alone’ condition, in terms of natural-log-transformed area-under-the-curve (AUC) and peak concentration (Cmax) values, with the exception of Cmax for OH-THC.
Cannabinoids and drug-drug pharmacokinetic interactions: Deciphering the risks.
A new review in the British Journal of Clinical Pharmacology examines cannabinoid drug interactions clinical monitoring requirements. The analysis highlights the need for systematic assessment of cannabis use when prescribing medications. Healthcare providers require better guidance for managing patients using cannabis alongside conventional treatments.
Metformin reverses oxandrolone-induced anxiety-like behavior and amygdalar neurochemical dysregulation in male rats.
Oxandrolone, a synthetic anabolic androgenic steroid, is widely used for its muscle-building effects but has been associated with anxiety and mood disturbanc…
Safety and Efficacy of Monoamine Oxidase Inhibitors in Patients Who Use Psychoactive Substances: Potential Drug Interactions and Substance Use Disorder Treatment Data.
Monoamine oxidase inhibitors (MAOIs) remain an important option for patients with treatment-resistant depression (TRD) and other psychiatric conditions, desp…
Plasma cannabinoid pharmacokinetics following the inhalation of vaporised cannabis with and without cannabidiol.
The presence of cannabidiol (CBD) in cannabis may alter cannabinoid pharmacokinetics, however previous research has produced mixed results. Furthermore, no p…